Report for Innocenti F

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs - Milano_2022_Cancer.Sci__
Author(s) : Milano G , Innocenti F , Minami H
Ref : Cancer Sci , : , 2022
Abstract : Milano_2022_Cancer.Sci__
ESTHER : Milano_2022_Cancer.Sci__
PubMedSearch : Milano_2022_Cancer.Sci__
PubMedID: 35445479

Title : Pharmacogenetic analysis of interindividual irinotecan (CPT-11) pharmacokinetic (PK) variability: Evidence for a functional variant of ABCC2 - Innocenti_2004_J.Clin.Oncol_22_2010
Author(s) : Innocenti F , Undevia SD , Chen PX , Das S , Ramirez J , Dolan ME , Relling MV , Kroetz DL , Ratain MJ
Ref : J Clin Oncol , 22 :2010 , 2004
Abstract : Innocenti_2004_J.Clin.Oncol_22_2010
ESTHER : Innocenti_2004_J.Clin.Oncol_22_2010
PubMedSearch : Innocenti_2004_J.Clin.Oncol_22_2010
PubMedID: 28015612